Biogen Inc (NASDAQ:BIIB) Hires Away Pfizer (PFE)’s Chief Neuroscientist

Biogen Inc (NASDAQ:BIIB) has hired Michael Ehlers as the head of its research and development unit. Until his hiring by Biogen, Ehlers was Pfizer Inc. (NYSE:PFE)’s chief neuroscientist as well as VP for biotherapeutics research and development. Perhaps the latest talent outflow adds to the multiple pains that Pfizer has suffered in recent years. The company was recently forced to pull out of a deal that would have seen shift its corporate headquarters to Ireland in a tax inversion transaction. Hiring of Ehlers sees Biogen Inc (NASDAQ:BIIB) fill a critical position that has been lying vacant for nearly nine months. Ehlers, 47, is coming in to replace former Biogen head of R&D, Doug Williams, who left the company to lead a biotech startup. What is Ehlers bringing to the table?…


Link to Full Article: Biogen Inc (NASDAQ:BIIB) Hires Away Pfizer (PFE)’s Chief Neuroscientist